Published in Nat Genet on August 01, 1996
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet (2005) 2.17
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci U S A (2000) 2.13
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J (1998) 2.07
FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev (2005) 1.99
Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry (2006) 1.96
Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet (2004) 1.92
Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet (2002) 1.88
Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes Dev (1998) 1.79
Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci U S A (1998) 1.64
Targeting mutant fibroblast growth factor receptors in cancer. Trends Mol Med (2011) 1.51
De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet (1999) 1.50
Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis. J Med Genet (1997) 1.18
Molecular genetics of craniosynostotic syndromes. Graefes Arch Clin Exp Ophthalmol (1997) 1.04
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol (1999) 1.02
A Genetic-Pathophysiological Framework for Craniosynostosis. Am J Hum Genet (2015) 1.02
Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye? Cell Adh Migr (2010) 1.01
Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses. Curr Genet Med Rep (2014) 0.91
Familial craniosynostosis, anal anomalies, and porokeratosis: CAP syndrome. J Med Genet (1998) 0.91
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. J Clin Invest (2012) 0.90
Novel FGFR2 deletion in a patient with Beare-Stevenson-like syndrome. Am J Med Genet A (2009) 0.88
New therapeutic targets in rare genetic skeletal diseases. Expert Opin Orphan Drugs (2015) 0.87
The first Korean case of Beare-Stevenson syndrome with a Tyr375Cys mutation in the fibroblast growth factor receptor 2 gene. J Korean Med Sci (2007) 0.84
Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells. Mol Cell Biol (1997) 0.84
Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis. PLoS One (2014) 0.78
Syndromic craniosynostosis, fibroblast growth factor receptor 2 (FGFR2) mutations, and sacrococcygeal eversion presenting as human tails. Childs Nerv Syst (2012) 0.76
Genetic advances in craniosynostosis. Am J Med Genet A (2017) 0.76
A Case of Beare-Stevenson Syndrome with Unusual Manifestations. Am J Case Rep (2016) 0.75
Echotomography of craniosynostosis: review of literature. J Prenat Med (2009) 0.75
Apparently synonymous substitutions in FGFR2 affect splicing and result in mild Crouzon syndrome. BMC Med Genet (2014) 0.75
Signaling pathways in osteogenesis and osteoclastogenesis: Lessons from cranial sutures and applications to regenerative medicine. Genes Dis (2015) 0.75
Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase. Front Pharmacol (2017) 0.75
Codon selection in yeast. J Biol Chem (1982) 19.13
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
Origins and affinities of modern humans: a comparison of mitochondrial and nuclear genetic data. Am J Hum Genet (1995) 17.65
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Sequence of the gene for iso-1-cytochrome c in Saccharomyces cerevisiae. Cell (1979) 10.86
Nucleotide sequence of a mutant eukaryotic gene: the yeast tyrosine-inserting ochre suppressor SUP4-o. Proc Natl Acad Sci U S A (1977) 10.64
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med (2000) 7.38
The primary structure of the Saccharomyces cerevisiae gene for alcohol dehydrogenase. J Biol Chem (1982) 7.03
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell (1990) 6.94
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Characteristics of the BGM line of cells from African green monkey kidney. Brief report. Arch Gesamte Virusforsch (1970) 6.50
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (1998) 6.49
Deletion mapping of sequences essential for in vivo transcription of the iso-1-cytochrome c gene. Proc Natl Acad Sci U S A (1981) 6.26
RSC, an essential, abundant chromatin-remodeling complex. Cell (1996) 6.17
Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev (1998) 5.79
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol (1998) 5.79
The sequence of the DNAs coding for the mating-type loci of Saccharomyces cerevisiae. Cell (1981) 5.23
A position effect in the control of transcription at yeast mating type loci. Nature (1981) 5.23
Phylogenetic relationships among ascomycetes: evidence from an RNA polymerse II subunit. Mol Biol Evol (1999) 4.83
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet (1996) 4.21
T-cell co-stimulation through B7RP-1 and ICOS. Nature (1999) 4.20
Mutation of a heterothallic strain to homothallism. Genetics (1975) 4.09
Macromolecule synthesis and breakdown in relation to sporulation and meiosis in yeast. J Bacteriol (1974) 4.07
Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med (1989) 3.97
Transcriptional regulation of the yeast cytochrome c gene. Proc Natl Acad Sci U S A (1979) 3.85
Syndromes with cleft lip and cleft palate. Cleft Palate J (1978) 3.84
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature (1982) 3.82
Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell (1998) 3.71
Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet (1997) 3.70
Isolation and sequence of the gene for iso-2-cytochrome c in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1980) 3.62
The homeobox gene GLABRA2 is required for position-dependent cell differentiation in the root epidermis of Arabidopsis thaliana. Development (1996) 3.59
The airway: problems and predictions in 18,500 patients. Can J Anaesth (1994) 3.46
Registries and administrative data: organization and accuracy. Med Care (1993) 3.44
Identification and isolation of the yeast cytochrome c gene. Cell (1978) 3.39
CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) (1998) 3.33
Identification of the yeast DNA sequences that correspond to specific tyrosine-inserting nonsense suppressor loci. J Mol Biol (1979) 3.29
Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet (1989) 3.27
Mutations of the yeast SUP4 tRNATyr locus: transcription of the mutant genes in vitro. Cell (1980) 3.24
Cardio-facio-cutaneous syndrome phenotype in an individual with an interstitial deletion of 12q: identification of a candidate region for CFC syndrome. Am J Med Genet (2000) 3.22
Reliability of the timeline follow-back sexual behavior interview. Ann Behav Med (1998) 3.15
Isolation and characterization of non-defective transducing elements of bacteriophage phi-80. Virology (1967) 3.15
In vitro mutation analysis of the mating-type locus in yeast. Cell (1981) 3.09
Deep common ancestry of indian and western-Eurasian mitochondrial DNA lineages. Curr Biol (1999) 3.06
Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02
Choanal atresia and associated multiple anomalies. J Pediatr (1979) 2.98
Older paternal age and fresh gene mutation: data on additional disorders. J Pediatr (1975) 2.97
The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet (2000) 2.91
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
The Proteus syndrome: the Elephant Man diagnosed. Br Med J (Clin Res Ed) (1986) 2.73
Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation (1999) 2.68
U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes Dev (1997) 2.67
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer (1977) 2.66
Effect of umbilical vein oxytocin on puerperal blood loss and length of the third stage of labor. Am J Obstet Gynecol (1989) 2.64
Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav (2002) 2.62
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55
Effects of tRNATyr point mutations on the binding of yeast RNA polymerase III transcription factor C. J Biol Chem (1986) 2.55
Histone octamer transfer by a chromatin-remodeling complex. Cell (1999) 2.54
X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet (1994) 2.53
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet (1995) 2.51
A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet (2000) 2.48
The amniotic band disruption complex: timing of amniotic rupture and variable spectra of consequent defects. J Pediatr (1979) 2.46
Expression of a human gene for interferon in yeast. Nature (1981) 2.46
Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids. Am J Hum Genet (1986) 2.45
Transcription in yeast: separation and properties of multiple FNA polymerases. Proc Natl Acad Sci U S A (1972) 2.45
Cloning of the yeast tyrosine transfer RNA genes in bacteriophage lambda. J Mol Biol (1979) 2.44
Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery (1999) 2.44
Predicting difficult intubation: a multivariable analysis. Can J Anaesth (2000) 2.41
Mating type and sporulation in yeast. I. Mutations which alter mating-type control over sporulation. Genetics (1975) 2.41
Metabolic Engineering of a Pentose Metabolism Pathway in Ethanologenic Zymomonas mobilis. Science (1995) 2.40
Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet (1997) 2.39
In vivo and in vitro chromosomal damage induced by LSD-25. N Engl J Med (1967) 2.39
Activated RSC-nucleosome complex and persistently altered form of the nucleosome. Cell (1998) 2.38
Testing the raters: inter-rater reliability of standardized anaesthesia simulator performance. Can J Anaesth (1997) 2.37
Craniosynostoses: phenotypic/molecular correlations. Am J Med Genet (1995) 2.35
A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1991) 2.33
Isolation of a gene from Drosophila by complementation in yeast. Nature (1981) 2.30
A revised and extended classification of the distal arthrogryposes. Am J Med Genet (1996) 2.30
The primary structure of the alcohol dehydrogenase gene from the fission yeast Schizosaccharomyces pombe. J Biol Chem (1983) 2.29
Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem (2001) 2.26
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat (1999) 2.24
Saccadic dysmetria and adaptation after lesions of the cerebellar cortex. J Neurosci (1999) 2.24
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia (2010) 2.22
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
Incidence of fibrocystic disease in Wessex. J Med Genet (1968) 2.22
Colon and rectal anastomoses do not require routine drainage: a systematic review and meta-analysis. Ann Surg (1999) 2.20
Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem (1994) 2.20
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
Deletion of Huntington's disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature (1985) 2.19
Transcription initiation of eucaryotic transfer RNA genes. Cell (1982) 2.18
Why is there no progress against cervical cancer? CMAJ (1996) 2.14
Self-perceived health and 5-year mortality risks among the elderly in Shanghai, China. Am J Epidemiol (1998) 2.14
Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. Am J Hum Genet (1995) 2.13
THE OCCURRENCE OF NATURAL DNA-RNA COMPLEXES IN E. COLI INFECTED WITH T2. Proc Natl Acad Sci U S A (1961) 2.12